Nomura Asset Management’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-300
Closed -$17.8K 1543
2026
Q1
$17.8K Hold
300
﹤0.01% 1475
2025
Q4
$18.5K Hold
300
﹤0.01% 1440
2025
Q3
$18.7K Hold
300
﹤0.01% 1451
2025
Q2
$24K Hold
300
﹤0.01% 1364
2025
Q1
$25.8K Hold
300
﹤0.01% 1334
2024
Q4
$23.4K Hold
300
﹤0.01% 1330
2024
Q3
$21.6K Hold
300
﹤0.01% 1374
2024
Q2
$20.7K Hold
300
﹤0.01% 1357
2024
Q1
$21.8K Hold
300
﹤0.01% 1353
2023
Q4
$18.4K Hold
300
﹤0.01% 1384
2023
Q3
$17.2K Hold
300
﹤0.01% 1373
2023
Q2
$17.8K Hold
300
﹤0.01% 1393
2023
Q1
$18.8K Sell
300
-170
-36% -$10.6K ﹤0.01% 1348
2022
Q4
$29.4K Hold
470
﹤0.01% 1193
2022
Q3
$23.4K Hold
470
﹤0.01% 1247
2022
Q2
$27.6K Hold
470
﹤0.01% 1225
2022
Q1
$24.9K Buy
+470
New +$27.1K ﹤0.01% 1326

Other funds holding PBH

Nomura Asset Management's PBH Position: Q2 2026 in Review

Nomura Asset Management sold out of Prestige Consumer Healthcare (PBH) in Q2 2026, closing a stake of 300 shares — an estimated $17.8K sold.

Nomura Asset Management first reported a position in PBH in Q1 2022 and held it in 17 quarters. The position peaked at $29.4K in Q4 2022. 318 funds tracked by Wall St. Rank hold PBH as of Q2 2026.

  • Nomura Asset Management reported no remaining Prestige Consumer Healthcare position as of Q2 2026 after selling out during the quarter.
  • Nomura Asset Management sold 300 Prestige Consumer Healthcare shares in Q2 2026, an estimated $17.8K.
  • Nomura Asset Management first reported a position in Prestige Consumer Healthcare in Q1 2022 and held it in 17 quarters.
  • Nomura Asset Management's Prestige Consumer Healthcare position peaked at $29.4K in Q4 2022.
  • 318 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2026.

Based on Nomura Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.